Found: 12
Select item for more details and to access through your institution.
Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients.
- Published in:
- Pharmacogenomics Journal, 2013, v. 13, n. 6, p. 484, doi. 10.1038/tpj.2012.46
- By:
- Publication type:
- Article
High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study.
- Published in:
- Pharmacogenomics Journal, 2012, v. 12, n. 6, p. 499, doi. 10.1038/tpj.2011.34
- By:
- Publication type:
- Article
Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians.
- Published in:
- Pharmacogenomics Journal, 2011, v. 11, n. 2, p. 130, doi. 10.1038/tpj.2010.16
- By:
- Publication type:
- Article
Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 90, n. 3, p. 406, doi. 10.1038/clpt.2011.129
- By:
- Publication type:
- Article
Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2010, v. 88, n. 5, p. 676, doi. 10.1038/clpt.2010.172
- By:
- Publication type:
- Article
CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir.
- Published in:
- Clinical Pharmacology & Therapeutics, 2007, v. 81, n. 5, p. 708, doi. 10.1038/sj.clpt.6100117
- By:
- Publication type:
- Article
Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C greater than A polymorphism.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure -- an impact similar to male gender or smoking in schizophrenic patients.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Rebuttal: Response to the comments by Buck et al. on our published article: Hepatic and renal toxicity and associated factors among HIV‐infected children on antiretroviral therapy: a prospective cohort study; HIV Medicine (2019), 20, 147–156
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Hepatic and renal toxicity and associated factors among HIV‐infected children on antiretroviral therapy: a prospective cohort study.
- Published in:
- HIV Medicine, 2019, v. 20, n. 2, p. 147, doi. 10.1111/hiv.12693
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3311, doi. 10.1093/jac/dku286
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4[beta]-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article